Valérie Rouffiac

915 total citations
31 papers, 694 citations indexed

About

Valérie Rouffiac is a scholar working on Biomedical Engineering, Molecular Biology and Cancer Research. According to data from OpenAlex, Valérie Rouffiac has authored 31 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Biomedical Engineering, 14 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Valérie Rouffiac's work include Angiogenesis and VEGF in Cancer (12 papers), Ultrasound and Hyperthermia Applications (10 papers) and Photoacoustic and Ultrasonic Imaging (6 papers). Valérie Rouffiac is often cited by papers focused on Angiogenesis and VEGF in Cancer (12 papers), Ultrasound and Hyperthermia Applications (10 papers) and Photoacoustic and Ultrasonic Imaging (6 papers). Valérie Rouffiac collaborates with scholars based in France, United States and Italy. Valérie Rouffiac's co-authors include Paule Opolon, Nathalie Lassau, Michel Perricaudet, Ariane Galaup, Frank Griscelli, Claire Magnon, P. Péronneau, Jean‐Michel Bidart, Brian P. Mullan and Serge Koscielny and has published in prestigious journals such as Cancer Research, Scientific Reports and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Valérie Rouffiac

31 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Valérie Rouffiac France 16 302 190 189 182 127 31 694
Zili An United States 15 228 0.8× 369 1.9× 113 0.6× 112 0.6× 76 0.6× 24 797
Carsten Dan Ley Denmark 10 305 1.0× 119 0.6× 115 0.6× 147 0.8× 140 1.1× 26 727
Joost A.P. Rens Netherlands 12 266 0.9× 148 0.8× 197 1.0× 91 0.5× 55 0.4× 15 596
Wuhu Zhang China 14 320 1.1× 492 2.6× 115 0.6× 181 1.0× 56 0.4× 38 969
Motomu Kuroki Japan 11 224 0.7× 129 0.7× 161 0.9× 89 0.5× 85 0.7× 13 561
Jaime Fornetti United States 8 209 0.7× 324 1.7× 87 0.5× 93 0.5× 68 0.5× 11 639
Elisabeth J. M. Huijbers Netherlands 19 697 2.3× 486 2.6× 127 0.7× 347 1.9× 66 0.5× 35 1.3k
Kenneth C. Valkenburg United States 7 446 1.5× 526 2.8× 215 1.1× 233 1.3× 61 0.5× 8 1.1k
Edwardine Labay United States 12 540 1.8× 415 2.2× 167 0.9× 223 1.2× 94 0.7× 14 1.1k
Iván Martínez‐Forero Spain 20 297 1.0× 825 4.3× 96 0.5× 112 0.6× 81 0.6× 29 1.4k

Countries citing papers authored by Valérie Rouffiac

Since Specialization
Citations

This map shows the geographic impact of Valérie Rouffiac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valérie Rouffiac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valérie Rouffiac more than expected).

Fields of papers citing papers by Valérie Rouffiac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valérie Rouffiac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valérie Rouffiac. The network helps show where Valérie Rouffiac may publish in the future.

Co-authorship network of co-authors of Valérie Rouffiac

This figure shows the co-authorship network connecting the top 25 collaborators of Valérie Rouffiac. A scholar is included among the top collaborators of Valérie Rouffiac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valérie Rouffiac. Valérie Rouffiac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abdesselem, Mouna, Valérie Rouffiac, Thierry Gacoin, et al.. (2023). Real-time in vivo ROS monitoring with luminescent nanoparticles reveals skin inflammation dynamics. Biomedical Optics Express. 14(10). 5392–5392. 3 indexed citations
2.
Gall, Morgane Le, Denis Clay, Sébastien Jacques, et al.. (2022). Endothelial and hematopoietic hPSCs differentiation via a hematoendothelial progenitor. Stem Cell Research & Therapy. 13(1). 254–254. 8 indexed citations
3.
Rouffiac, Valérie, Frédéric De Leeuw, Corinne Laplace‐Builhé, et al.. (2020). Cord blood-endothelial colony forming cells are immunotolerated and participate at post-ischemic angiogenesis in an original dorsal chamber immunocompetent mouse model. Stem Cell Research & Therapy. 11(1). 172–172. 18 indexed citations
4.
Pawlikowska, Patrycja, Marianne Oulhen, Vincent Faugeroux, et al.. (2020). Exploitation of the chick embryo chorioallantoic membrane (CAM) as a platform for anti-metastatic drug testing. Scientific Reports. 10(1). 16876–16876. 46 indexed citations
5.
Costa, Maria Eugénia Marques Da, Estelle Daudigeos‐Dubus, Anne Gomez‐Brouchet, et al.. (2018). Establishment and characterization of in vivo orthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG mice. Cancer Medicine. 7(3). 665–676. 12 indexed citations
6.
Bories, Christian, Philippe M. Loiseau, Valérie Rouffiac, et al.. (2017). Supramolecular Chitosan Micro-Platelets Synergistically Enhance Anti-Candida albicans Activity of Amphotericin B Using an Immunocompetent Murine Model. Pharmaceutical Research. 34(5). 1067–1082. 25 indexed citations
7.
Taylor, Mélissa, Fanny Billiot, Virginie Marty, et al.. (2012). Reversing Resistance to Vascular-Disrupting Agents by Blocking Late Mobilization of Circulating Endothelial Progenitor Cells. Cancer Discovery. 2(5). 434–449. 37 indexed citations
8.
Leguerney, Ingrid, Nathalie Lassau, Serge Koscielny, et al.. (2010). Combining functional imaging and interstitial pressure measurements to evaluate two anti-angiogenic treatments. Investigational New Drugs. 30(1). 144–156. 11 indexed citations
9.
Bielawska‐Pohl, Aleksandra, Séverine Blesson, Houssem Benlalam, et al.. (2010). The anti-angiogenic activity of IL-12 is increased in iNOS−/− mice and involves NK cells. Journal of Molecular Medicine. 88(8). 775–784. 17 indexed citations
10.
Lejeune, Pascale, Valérie Rouffiac, Nicolas Elie, et al.. (2008). Early Quantitative Evaluation of a Tumor Vasculature Disruptive Agent AVE8062 Using Dynamic Contrast-Enhanced Ultrasonography. Investigative Radiology. 43(2). 100–111. 73 indexed citations
11.
Rouffiac, Valérie, et al.. (2007). Acoustic characterization of a new trisacryl contrast agent. Part I: In vitro study. Ultrasonics. 48(1). 16–25. 4 indexed citations
12.
Péronneau, P., Valérie Rouffiac, Angélo Paci, et al.. (2007). Acoustic characterization of a new trisacryl contrast agent. Part II: Flow phantom study and in vivo quantification. Ultrasonics. 48(1). 26–34. 1 indexed citations
13.
Rouffiac, Valérie, et al.. (2006). Combination of HIFU therapy with contrast-enhanced sonography for quantitative assessment of therapeutic efficiency on tumor grafted mice. Ultrasound in Medicine & Biology. 32(5). 729–740. 20 indexed citations
14.
Magnon, Claire, Ariane Galaup, Valérie Rouffiac, et al.. (2006). Dynamic assessment of antiangiogenic therapy by monitoring both tumoral vascularization and tissue degeneration. Gene Therapy. 14(2). 108–117. 24 indexed citations
15.
Magnon, Claire, Ariane Galaup, Brian P. Mullan, et al.. (2005). Canstatin Acts on Endothelial and Tumor Cells via Mitochondrial Damage Initiated through Interaction with αvβ3 and αvβ5 Integrins. Cancer Research. 65(10). 4353–4361. 117 indexed citations
16.
Paci, Angélo, Valérie Rouffiac, Paule Opolon, et al.. (2005). In Vitro Echogenicity Characterization of Poly[lactide-coglycolide] (PLGA) Microparticles and Preliminary In Vivo Ultrasound Enhancement Study for Ultrasound Contrast Agent Application. Investigative Radiology. 40(8). 536–544. 13 indexed citations
17.
Kaliski, Alexandre, Laurence Maggiorella, Denis Mathé, et al.. (2004). Antiangiogenic effect and tumor growth control achieved by an MMP-inhibitor combined to radiation in vivo, targeting radio-induced MMP-2 enhancement and VEGF modulation. International Journal of Radiation Oncology*Biology*Physics. 60. S368–S369. 1 indexed citations
18.
Lassau, Nathalie, Michele Lamuraglia, J. Leclère, & Valérie Rouffiac. (2004). Évaluation fonctionnelle et précoce des traitements en cancérologie : intérêt des produits de contraste ultrasonores. Journal de Radiologie. 85(5). 704–712. 24 indexed citations
19.
Kaliski, Alexandre, Nathalie Lassau, Laurence Maggiorella, et al.. (2004). Antiangiogenic effect and tumor growth control achieved by an MMP-inhibitor combined to radiation in vivo, targeting radio-induced MMP-2 enhancement and VEGF modulation. International Journal of Radiation Oncology*Biology*Physics. 60(1). S368–S369. 1 indexed citations
20.
Bessoud, B., Nathalie Lassau, Serge Koscielny, et al.. (2003). High-frequency sonography and color Doppler in the management of pigmented skin lesions. Ultrasound in Medicine & Biology. 29(6). 875–879. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026